Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. Wilens TE, et al. Among authors: bukstein o. Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90. doi: 10.1001/archpedi.160.1.82. Arch Pediatr Adolesc Med. 2006. PMID: 16389216 Clinical Trial.
Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, Lane DM, Loveland KA, Bukstein OG, Jerger SW, Factor P, Vanwoerden S, Perez E, Cleveland LA. Pearson DA, et al. J Child Adolesc Psychopharmacol. 2013 Jun;23(5):337-51. doi: 10.1089/cap.2012.0096. J Child Adolesc Psychopharmacol. 2013. PMID: 23782128 Free PMC article. Clinical Trial.
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.
Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, Arnold LE, Abikoff HB, Bukstein OG, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Wells K, Wigal T. Greenhill LL, et al. Among authors: bukstein og. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):180-7. doi: 10.1097/00004583-200102000-00012. J Am Acad Child Adolesc Psychiatry. 2001. PMID: 11211366 Clinical Trial.
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.
Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, Elliott GR, Hechtman L, Jensen PS, Hinshaw SP, March JS, Newcorn JH, Swanson JM, Cantwell DP. Vitiello B, et al. Among authors: bukstein og. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):188-96. doi: 10.1097/00004583-200102000-00013. J Am Acad Child Adolesc Psychiatry. 2001. PMID: 11211367 Clinical Trial.
Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Pearson DA, Santos CW, Aman MG, Arnold LE, Lane DM, Loveland KA, Mansour R, Ward AR, Casat CD, Jerger S, Schachar RJ, Bukstein OG, Cleveland LA. Pearson DA, et al. Among authors: bukstein og. J Child Adolesc Psychopharmacol. 2020 Sep;30(7):414-426. doi: 10.1089/cap.2020.0004. Epub 2020 Jul 9. J Child Adolesc Psychopharmacol. 2020. PMID: 32644833 Free PMC article.
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S; American Academy of Child and Adolescent Psychiatry. Greenhill LL, et al. Among authors: bukstein o. J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S. doi: 10.1097/00004583-200202001-00003. J Am Acad Child Adolesc Psychiatry. 2002. PMID: 11833633 Review.
149 results